HENRY SCHEIN, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
HENRY SCHEIN, INC. (HSIC) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$12.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2023-02-21
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-03-26 was $4.00M, a 33.33% increase year-over-year.
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2021-03-27 was $3.00M.
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2020-03-28 was -$5.49M, a 153.05% decline year-over-year.
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2019-03-30 was $10.35M.
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$12.00M.
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2021 was -$3.00M, a 116.67% decline from fiscal 2020.
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2020 was $18.00M, a 25.05% increase from fiscal 2019.
- HENRY SCHEIN, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2019 was $14.39M, a 0.21% decline from fiscal 2018.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$12.00M 10-K · filed 2023-02-21 | ||||||
| 2022-06-25 | -$6.00M 10-Q · filed 2022-08-02 | ||||||
| 2022-03-26 | $4.00M 10-Q · filed 2022-05-03 | ||||||
| 2021-12-25 | -$3.00M 10-K · filed 2023-02-21 | -$2.63M 10-K · filed 2022-02-15 | |||||
| 2021-09-25 | -$1.52M 10-Q · filed 2021-11-02 | ||||||
| 2021-06-26 | $4.00M 10-Q · filed 2022-08-02 | $4.83M 10-Q · filed 2021-08-03 | |||||
| 2021-03-27 | $3.00M 10-Q · filed 2022-05-03 | $2.71M 10-Q · filed 2021-05-04 | |||||
| 2020-12-26 | $18.00M 10-K · filed 2023-02-21 | $18.38M 10-K · filed 2021-02-17 | |||||
| 2020-09-26 | $8.51M 10-Q · filed 2021-11-02 | ||||||
| 2020-06-27 | $10.45M 10-Q · filed 2021-08-03 | ||||||
| 2020-03-28 | -$5.49M 10-Q · filed 2021-05-04 | ||||||
| 2019-12-28 | $14.39M 10-K · filed 2022-02-15 | ||||||
| 2019-09-28 | $8.40M 10-Q · filed 2020-11-02 | ||||||
| 2019-06-29 | $4.51M 10-Q · filed 2020-08-04 | ||||||
| 2019-03-30 | $10.35M 10-Q · filed 2020-05-05 | ||||||
| 2018-12-29 | $14.43M 10-K · filed 2021-02-17 | ||||||
| 2018-09-29 | $14.51M 10-Q · filed 2019-11-05 | ||||||
| 2018-06-30 | $13.30M 10-Q · filed 2019-08-06 | ||||||
| 2017-12-30 | $26.98M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |